Related Experiment Video
Updated: Jul 3, 2026

Stem Cell-Derived Viral Ag-Specific T Lymphocytes Suppress HBV Replication in Mice
Published on: September 25, 2019
A preS2 aa1-26-specific humoural response marks functional cure in chronic HBV infection
You-Yuan Wang1, Jun-Liang Fu1, Wen-Xin Wang2
1Senior Department of Infectious Diseases, Chinese PLA General Hospital, Beijing, China; PLA Medical School, Beijing, China.
Background:
Functional cure (FC) of chronic hepatitis B (CHB) is closely associated with restoration of HBV-specific humoural immunity, yet the epitope-resolved features of humoural immunity recovery during interferon-induced FC remain unknown.
Methods:
We profiled HBV-specific humoural responses in 65 patients with CHB drawn from three independent PEG-IFNα-treated cohorts, including nucleos(t)ide analogue-treated patients with viral suppression and inactive HBsAg carriers. Linear epitope mapping was performed using phage immunoprecipitation sequencing (PhIP-seq), with key findings validated by longitudinal ELISA and complemented by ex vivo phenotypic characterisation of epitope-specific B cells using fluorescent peptide tetramers.
Findings:
PhIP-seq identified 297 reactive peptides, with a marked enrichment of antibody reactivity toward the HBsAg preS domain in patients who achieved FC. Longitudinal analysis demonstrated that preS2-directed antibodies, particularly those targeting the N-terminal amino acids 1-26 (preS2 aa1-26), increased progressively and closely parallelled HBsAb seroconversion, consistently distinguishing FC from non-FC group. In parallel, ex vivo B-cell profiling revealed that preS2 aa1-26-specific B cells exhibited a plasmablast-skewed and IgG-dominant profile, in contrast to the more IgM-biased and less differentiated phenotypes observed in preS1- and SHBs-specific B cells. Within the preS2-specific compartment, FC showed higher CXCR5 and CD69 expression than non-FC group, indicative of enhanced maturation and improved follicular homing potential.
Interpretation:
PreS2 aa1-26 may serve as a key humoural HBV-specific epitope associated with functional cure, with potential implications for immunotherapeutic strategies in CHB.
Funding:
This work was supported by the National Science and Technology Major Project (2025ZD01905905), National Key Research and Development Program of China (2022YFA1303600 and 2023YFC2308100), and the National Natural Science Foundation of China (82130019 and 82272311).
More Related Videos
10:37Analysis of HBV-Specific CD4 T-cell Responses and Identification of HLA-DR-Restricted CD4 T-Cell Epitopes Based on a Peptide Matrix
Published on: October 20, 2021
11:34A Competent Hepatocyte Model Examining Hepatitis B Virus Entry through Sodium Taurocholate Cotransporting Polypeptide as a Therapeutic Target
Published on: May 10, 2022
Related Concept Videos
Humoral Immune Responses
Hybridoma Technology
Hybridoma Selection
Commonly used fusion techniques — electroporation, polyethylene glycol...
B Cell Activation and Differentiation
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
Immune Response Against Viral Pathogens
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Hepatitis
Viral Hepatitis I: Introduction